HAP Trading’s Amicus Therapeutics FOLD Stock Holding History

HAP Trading’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-23,000	Closed	-$27K	–	2533
2021 Q2	$27K	Sell	23,000 -32,000	-58%	-$312K	﹤0.01%	1714
2021 Q1	$471K	Sell	55,000 -229,300	-81%	-$3.55M	0.03%	504
2020 Q4	$304K	Buy	+284,300	New	+$5.81M	0.01%	804
2019 Q2	–	Sell	-25,400	Closed	-$1K	–	1204
2019 Q1	$1K	Buy	+25,400	New	+$310K	﹤0.01%	1074
2018 Q2	–	Sell	-19,900	Closed	-$3K	–	1031
2018 Q1	$3K	Buy	+19,900	New	+$303K	﹤0.01%	871
2017 Q4	–	Sell	-158,000	Closed	-$20K	–	1060
2017 Q3	$20K	Buy	158,000 +40,200	+34%	+$532K	﹤0.01%	749
2017 Q2	$5K	Buy	117,800 +7,500	+7%	+$60.3K	﹤0.01%	882
2017 Q1	$30K	Buy	+110,300	New	+$697K	﹤0.01%	768
2016 Q2	–	Sell	-50,000	Closed	-$104K	–	959
2016 Q1	$104K	Buy	50,000 +10,000	+25%	+$70.8K	0.01%	454
2015 Q4	$84K	Buy	+40,000	New	+$360K	﹤0.01%	577

Other funds holding FOLD

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

HAP Trading's FOLD Position: Q4 2021 in Review

HAP Trading sold out of Amicus Therapeutics (FOLD) in Q4 2021, closing a stake of 26,527 shares — an estimated $296K sold.

HAP Trading first reported a position in FOLD in Q1 2017 and held it in 5 quarters. The position peaked at $1.18M in Q4 2020. 224 funds tracked by Wall St. Rank hold FOLD as of Q4 2021.

HAP Trading reported no remaining Amicus Therapeutics position as of Q4 2021 after selling out during the quarter.
HAP Trading sold 26,527 Amicus Therapeutics shares in Q4 2021, an estimated $296K.
HAP Trading first reported a position in Amicus Therapeutics in Q1 2017 and held it in 5 quarters.
HAP Trading's Amicus Therapeutics position peaked at $1.18M in Q4 2020.
224 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.